Inventor · disambiguated record
Chi V. Dang
Also filed as: DANG CHI V · DANG CHI VAN
6 granted patents·8 pending applications·17 citations·filing 2003–2024
78Inventor score
Files withUNIV JOHNS HOPKINS4US HEALTH3DANG CHI V2LUDWIG INST FOR CANCER RES LTD1NAT INSTITUTES OF HEALTH UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES1
Top patents by PatentIndex Score
14 records- 0194US11247971B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUS HEALTH·Filed 2021·Granted Feb 15, 2022·3 cites·17 claims
- 0290US10961200B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofTHE US SECRETARY DEPARTMENT OF HEALTH·Filed 2019·Granted Mar 30, 2021·4 cites·18 claims
- 0389US10351532B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUNIV VANDERBILT·Filed 2015·Granted Jul 16, 2019·8 cites·21 claims
- 0486US12365653B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUS HEALTH·Filed 2024·Granted Jul 22, 2025·0 cites·12 claims
- 0576US11897845B2Small molecule inhibitors of lactate dehydrogenase and methods of use thereofUS HEALTH·Filed 2022·Granted Feb 13, 2024·0 cites·19 claims
- 0673US10954228B21 H-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of use thereofNAT INSTITUTES OF HEALTH UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES·Filed 2017·Granted Mar 23, 2021·2 cites·18 claims
- 0758US2011177038A1Inhibition of Tumor Growth via Peroxiredoxin 3UNIV JOHNS HOPKINS·Filed 2008·Application pending·0 cites
- 0857US2015133524A1Pyruvate dehyrogenase kinases as theraeutic targets for cancer and ischemic diseasesUNIV JOHNS HOPKINS·Filed 2014·Application pending·0 cites
- 0949US2012003156A1Methods for treating neoplasia by inhibiting lactate dehydrogenase and/or nicotinamide phosphoribosyltransferaseDANG CHI V·Filed 2009·Application pending·0 cites
- 1047US2003228294A1Inhibition of tumor growth via peroxiredoxin 3UNIV JOHNS HOPKINS·Filed 2003·Application pending·0 cites
- 1146US2009209618A1Pyruvate dehydrogenase kinases as therapeutic targets for cancer and ischemic diseasesDANG CHI V·Filed 2005·Application pending·0 cites
- 1241US2022267781A1Immune cells with enhanced cytotoxicity and methods of use thereofLUDWIG INST FOR CANCER RES LTD·Filed 2020·Application pending·0 cites
- 1341US2009209621A1Compositions and methods for decreasing microrna expression for the treatment of neoplasiaUNIV JOHNS HOPKINS·Filed 2006·Application pending·0 cites
- 1440US2013109643A1Metabolic inhibitor against tumors having an idh mutationRIGGINS GREGORY JOSEPH·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chi V. Dang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →